Lv1
20 积分 2023-04-02 加入
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
3天前
已完结
Standardising busulfan dosage for children and young adults
1个月前
已完结
First-Line Unrelated Double-Unit Umbilical Cord Blood Transplantation for Acquired Severe Aplastic Anemia
2个月前
已完结
Unrelated cord blood transplantation for severe aplastic anemia using intensified immunoablative conditioning regimen leading to high engraftment and survival
2个月前
已完结
Successful treatment of very severe aplastic anemia with double unrelated umbilical cord blood transplantation in a donor-specific antigen positive adult patient: A case report and review
2个月前
已完结
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
2个月前
已完结
Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies
3个月前
已完结
Global distribution of β-thalassemia mutations: An update
3个月前
已完结
FDA’s New Plausible Mechanism Pathway
3个月前
已完结
In vivo genome editing of ANGPTL3: a therapy for atherosclerosis?
3个月前
已完结
皖公网安备34019202002308
